Thymosin Alpha-1 (10 mg vial)

Thymosin Alpha-1 (10 mg vial)

Primary use: Immune modulation and antiviral support

Mechanism / class: Synthetic 28–amino acid thymic peptide; T-cell–activating immunomodulator

Key effects:

• Enhances T-cell maturation and differentiation

• Increases natural killer (NK) cell activity

• Modulates cytokine signaling and immune balance

• Supports antiviral immune response

• May improve immune resilience in immunocompromised states

Clinical distinction:
Acts as a targeted immune enhancer, not a stimulant, hormone, or metabolic agent. Unlike general immune boosters, it specifically supports adaptive immunity through T-cell signaling. Used clinically in certain countries for viral infections and immune dysregulation; research-based and condition-specific in many regions.